Plunkett Research Online: Advanced Proteome Therapeutics Corp

ADVANCED PROTEOME THERAPEUTICS CORP (APC:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Advanced Proteome Therapeutics Corporation is developing a new technology platform that will shorten the time-to-market for the commercialization of protein therapeutics......



Advanced Proteome Therapeutics Corp
Ticker: APC
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 638-0340
Fax: 617 638-0341
Address: 650 Albany Street
Suite 113
BioSquare
Boston, MA 02118 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Research and Development in Biotechnology
ContactsDescription
Randal ChaseCEO/Director/President
Kenneth PhillippeCFO
See More
Advanced Proteome Therapeutics Corporation is developing a new technology platform that will shorten the time-to-market for the commercialization of protein therapeutics......See More See More

Auditor: BDO Dunwoody LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: